JP2007008900A - Hair growth promoter containing biflavones as active component - Google Patents
Hair growth promoter containing biflavones as active component Download PDFInfo
- Publication number
- JP2007008900A JP2007008900A JP2005194887A JP2005194887A JP2007008900A JP 2007008900 A JP2007008900 A JP 2007008900A JP 2005194887 A JP2005194887 A JP 2005194887A JP 2005194887 A JP2005194887 A JP 2005194887A JP 2007008900 A JP2007008900 A JP 2007008900A
- Authority
- JP
- Japan
- Prior art keywords
- hair
- growth
- biflavones
- hair growth
- isoginkgetin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003779 hair growth Effects 0.000 title claims abstract description 35
- 239000007952 growth promoter Substances 0.000 title abstract 2
- IWEIJEPIYMAGTH-UHFFFAOYSA-N Bilobetin Chemical compound COC1=CC=C(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)C=C1C1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 IWEIJEPIYMAGTH-UHFFFAOYSA-N 0.000 claims abstract description 14
- HUOOMAOYXQFIDQ-UHFFFAOYSA-N isoginkgetin Chemical compound C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C(C=3C(=CC=C(C=3)C=3OC4=CC(O)=CC(O)=C4C(=O)C=3)OC)=C2O1 HUOOMAOYXQFIDQ-UHFFFAOYSA-N 0.000 claims abstract description 12
- CGPVRBMMGYBFAC-UHFFFAOYSA-N isoginkgetin Natural products COc1ccc(cc1)C2=COc3c(C2=O)c(O)cc(O)c3c4cc(ccc4OC)C5=CC(=O)c6c(O)cc(O)cc6O5 CGPVRBMMGYBFAC-UHFFFAOYSA-N 0.000 claims abstract description 12
- YCXRBCHEOFVYEN-UHFFFAOYSA-N sciadopitysin Chemical compound C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C(C=3C(=CC=C(C=3)C=3OC4=CC(OC)=CC(O)=C4C(=O)C=3)OC)=C2O1 YCXRBCHEOFVYEN-UHFFFAOYSA-N 0.000 claims abstract description 12
- TYUMAYSMJLPFAN-UHFFFAOYSA-N 5,7-dihydroxy-8-[2-hydroxy-5-(5-hydroxy-7-methoxy-4-oxochromen-2-yl)phenyl]-2-(4-hydroxyphenyl)chromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C(C=1)=CC=C(O)C=1C1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 TYUMAYSMJLPFAN-UHFFFAOYSA-N 0.000 claims abstract description 10
- SQGLUEWZRKIEGS-UHFFFAOYSA-N Ginkgetin Natural products C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C=C(OC)C(C=3C(=CC=C(C=3)C=3OC4=CC(O)=CC(O)=C4C(=O)C=3)O)=C2O1 SQGLUEWZRKIEGS-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229930045534 Me ester-Cyclohexaneundecanoic acid Natural products 0.000 claims abstract description 10
- AIFCFBUSLAEIBR-UHFFFAOYSA-N ginkgetin Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C(C=1)=CC=C(OC)C=1C1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 AIFCFBUSLAEIBR-UHFFFAOYSA-N 0.000 claims abstract description 10
- VXQYICLHHMETFH-UHFFFAOYSA-N tetra-O-methylamentoflavone Natural products C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C=C(OC)C(C=3C(=CC=C(C=3)C=3OC4=CC(OC)=CC(O)=C4C(=O)C=3)OC)=C2O1 VXQYICLHHMETFH-UHFFFAOYSA-N 0.000 claims abstract description 6
- 210000004209 hair Anatomy 0.000 claims description 31
- 239000000203 mixture Substances 0.000 claims description 14
- 239000004480 active ingredient Substances 0.000 claims description 7
- 230000000694 effects Effects 0.000 abstract description 16
- 101000993347 Gallus gallus Ciliary neurotrophic factor Proteins 0.000 abstract description 5
- 239000000047 product Substances 0.000 description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 239000009429 Ginkgo biloba extract Substances 0.000 description 10
- 229940068052 ginkgo biloba extract Drugs 0.000 description 10
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- HITDPRAEYNISJU-UHFFFAOYSA-N amenthoflavone Natural products Oc1ccc(cc1)C2=COc3c(C2=O)c(O)cc(O)c3c4cc(ccc4O)C5=COc6cc(O)cc(O)c6C5=O HITDPRAEYNISJU-UHFFFAOYSA-N 0.000 description 8
- YUSWMAULDXZHPY-UHFFFAOYSA-N amentoflavone Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C(C=3C(=CC=C(C=3)C=3OC4=CC(O)=CC(O)=C4C(=O)C=3)O)=C2O1 YUSWMAULDXZHPY-UHFFFAOYSA-N 0.000 description 8
- HVSKSWBOHPRSBD-UHFFFAOYSA-N amentoflavone Natural products Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)c(c3O2)c4cc(ccc4O)C5=COc6cc(O)cc(O)c6C5=O HVSKSWBOHPRSBD-UHFFFAOYSA-N 0.000 description 8
- NQJGJBLOXXIGHL-UHFFFAOYSA-N podocarpusflavone A Natural products COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)c(c3O2)c4cc(ccc4O)C5=COc6cc(O)cc(O)c6C5=O NQJGJBLOXXIGHL-UHFFFAOYSA-N 0.000 description 8
- UFJORDZSBNSRQT-UHFFFAOYSA-N 3-(4-oxo-2-phenylchromen-3-yl)-2-phenylchromen-4-one Chemical compound O1C2=CC=CC=C2C(=O)C(C=2C(C3=CC=CC=C3OC=2C=2C=CC=CC=2)=O)=C1C1=CC=CC=C1 UFJORDZSBNSRQT-UHFFFAOYSA-N 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 210000005175 epidermal keratinocyte Anatomy 0.000 description 6
- 244000194101 Ginkgo biloba Species 0.000 description 5
- 235000008100 Ginkgo biloba Nutrition 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 201000004384 Alopecia Diseases 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 229960003632 minoxidil Drugs 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- 230000010261 cell growth Effects 0.000 description 3
- 230000004663 cell proliferation Effects 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 229930003944 flavone Natural products 0.000 description 3
- 150000002213 flavones Chemical class 0.000 description 3
- 235000011949 flavones Nutrition 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- -1 malonyl isoflavone glycoside Chemical compound 0.000 description 3
- 150000003505 terpenes Chemical class 0.000 description 3
- 238000011735 C3H mouse Methods 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 231100000360 alopecia Toxicity 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000031774 hair cycle Effects 0.000 description 2
- 210000003780 hair follicle Anatomy 0.000 description 2
- 230000003676 hair loss Effects 0.000 description 2
- 208000024963 hair loss Diseases 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- YXHVCZZLWZYHSA-UHFFFAOYSA-N (Z)-6-[8-pentadecenyl]salicylic acid Natural products CCCCCCC=CCCCCCCCC1=CC=CC(O)=C1C(O)=O YXHVCZZLWZYHSA-UHFFFAOYSA-N 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- YXHVCZZLWZYHSA-FPLPWBNLSA-N Ginkgoic acid Chemical compound CCCCCC\C=C/CCCCCCCC1=CC=CC(O)=C1C(O)=O YXHVCZZLWZYHSA-FPLPWBNLSA-N 0.000 description 1
- 241000721662 Juniperus Species 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 244000042664 Matricaria chamomilla Species 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 235000001916 dieting Nutrition 0.000 description 1
- 230000037228 dieting effect Effects 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000003658 preventing hair loss Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- JUJBNYBVVQSIOU-UHFFFAOYSA-M sodium;4-[2-(4-iodophenyl)-3-(4-nitrophenyl)tetrazol-2-ium-5-yl]benzene-1,3-disulfonate Chemical compound [Na+].C1=CC([N+](=O)[O-])=CC=C1N1[N+](C=2C=CC(I)=CC=2)=NC(C=2C(=CC(=CC=2)S([O-])(=O)=O)S([O-])(=O)=O)=N1 JUJBNYBVVQSIOU-UHFFFAOYSA-M 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 230000003797 telogen phase Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000003813 thin hair Effects 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
Images
Landscapes
- Pyrane Compounds (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
本発明は、ビフラボン類を有効成分とする育毛剤の開発に関する。 The present invention relates to the development of a hair restorer containing biflavones as active ingredients.
イチョウ葉より抽出したエキスは、血管拡張、血流増大、血管系の老化防止、特に脳の末梢血流の改善、神経障害等の治療を目的とした医薬品として用いられている。そして、皮膚外用剤(特開平4−321616号公報(特許文献1))や化粧料(特開平1−117816号公報(技術文献2))としても用途が拓かれている。 Extracts extracted from ginkgo biloba are used as pharmaceuticals for the purpose of treating vascular dilation, increasing blood flow, preventing aging of the vascular system, particularly improving peripheral blood flow in the brain, and treating neurological disorders. Applications have also been developed as external preparations for skin (JP-A-4-321616 (Patent Document 1)) and cosmetics (JP-A-1-117816 (Technical Document 2)).
また従来よりイチョウ葉エキス、センブリ、カミツレ等生薬成分が育毛剤としても広く用いられている。特にイチョウ葉エキスはその成分であるテルペン類、フラボン類の血行促進作用により育毛を促すことが知られており、たとえば、特許第2612012号公報(特許文献3)には「イチョウの葉を水溶性有機溶剤または含水水溶性有機溶剤で抽出したイチョウエキスを含有することを特徴とする育毛・養毛料。」が記載されている。 Conventionally, herbal ingredients such as ginkgo biloba extract, assembly, chamomile and the like have been widely used as hair restorers. In particular, Ginkgo biloba extract is known to promote hair growth by promoting blood circulation of its components, terpenes and flavones. For example, Japanese Patent No. 26122012 (Patent Document 3) discloses that “Ginkgo biloba leaves are water-soluble. The hair growth and hair nourishing agent characterized by containing a ginkgo biloba extract extracted with an organic solvent or a water-containing water-soluble organic solvent.
また、「総フラボノイド含量が15〜40重量%、総テルペノイド含量が2〜15重量%であるイチョウ抽出物を養毛成分として配合したことを特徴とする毛髪用化粧料。」(特開平10−287531号公報(技術文献4))についても開示されている。 Further, “a cosmetic for hair characterized in that a ginkgo biloba extract having a total flavonoid content of 15 to 40% by weight and a total terpenoid content of 2 to 15% by weight is blended as a hair nourishing ingredient” No. 287531 (Technical Document 4)) is also disclosed.
更には、特開平9−59166号公報(特許文献5)には、マロニルイソフラボン配糖体が育毛剤として有効との記載がある。 Furthermore, JP-A-9-59166 (Patent Document 5) describes that malonyl isoflavone glycoside is effective as a hair restorer.
以上のようにいずれの育毛剤も、イチョウ葉エキス中のテルペン類あるいはフラボン類の血行促進作用による育毛効果であり、直接的に育毛作用を有しているものではない。 As described above, any of the hair-growth agents has a hair-growth effect by the blood circulation promoting action of terpenes or flavones in the ginkgo biloba extract, and does not directly have a hair-growth action.
近年ストレスや急激なダイエット等で若い女性の間でも脱毛や薄毛に悩む人が増えつつあり、育毛に直接的に効果のある物質の開発が待たれている。
育毛に直接的に効果のある成分を見出し、有効な育毛剤の開発を課題とする。 Finding ingredients that are directly effective for hair growth and developing effective hair growth agents.
本発明者等は、上記課題を解決すべく鋭意努力した結果、ビフラボン類が育毛活性を有することを見出し、本発明を完成した。
すなわち、本発明は
(1)ビフラボン類を有効成分とする育毛剤、
(2)ビフラボン類がシアドピティシン(Sciadopitysin)、ギンクゲチン(Ginkgetin)、イソギンクゲチン(Isoginkgetin)、セキオイアフラボン(Sequoiaflavone)及びビロベチン(Bilobetin)のいずれか1又はそれらの混合物であることを特徴とする(1)記載の育毛剤、
(3)ギンクゲチンとイソギンクゲチンとの混合物又はシアドピティシンを有効成分とする育毛剤
に関する。
As a result of diligent efforts to solve the above-mentioned problems, the present inventors have found that biflavones have hair-growth activity and completed the present invention.
That is, the present invention
(1) Hair restorer containing biflavones as active ingredients,
(2) The biflavones are any one of Sciadopitysin, Ginkgetin, Isoginkgetin, Sequoiaflavone and Bilobetin or a mixture thereof (1) The hair restorer described,
(3) The present invention relates to a hair-restoring agent comprising a mixture of ginkgogetin and isoginkgetin or a chiadopiticin as an active ingredient.
本発明者等は、既に皮膚との接触において有害なサリチル酸誘導体を含まず、従来のイチョウ葉エキスの有効成分に加えて、有効成分の二重フラボン類や有機酸類等を含むイチョウ葉エキスを開発し出願している(特開2005−104921号(特許文献6))。 The present inventors have already developed a ginkgo biloba extract that does not contain salicylic acid derivatives that are harmful in contact with the skin, and that contains the active ingredient double flavones and organic acids in addition to the active ingredient of the conventional ginkgo biloba extract. (Japanese Patent Laid-Open No. 2005-104921 (Patent Document 6)).
本発明者等は更に数多くの実験をした結果、イチョウ葉エキス中のビフラボン類とその混合物は、毛包上皮細胞類縁細胞であるところの、ヒト表皮角化細胞(HEKs)に対する顕著な増殖活性を有するとともに、C3Hマウス休止期毛の成長期への移行促進効果を有することを見出した。 As a result of further experiments, the present inventors have found that biflavones and mixtures thereof in ginkgo biloba extract have a proliferative activity against human epidermal keratinocytes (HEKs), which are hair follicle epithelial cell-related cells. And having the effect of promoting the transition of the resting hair of C3H mice to the growth phase.
毛髪には成長期、退行期、休止期を循環する、いわゆる毛周期(ヘアーサイクル)が存在する。正常な毛髪では成長期が5〜7年続き、数ヶ月間の退行期と休止期の後、脱毛し、また毛根が形成して毛髪が成長期に移行する。 Hair has a so-called hair cycle that circulates through the growth, regression, and rest periods. In normal hair, the growth period lasts 5 to 7 years, and after several months of regression and rest periods, hair loss occurs, and hair roots form and the hair enters the growth period.
一方、多くの脱毛症患者の毛髪では、成長期が2年未満に短縮し、休止期が極端に延長して、成長期に移行しないことが知られている。 On the other hand, in the hair of many alopecia patients, it is known that the growth period is shortened to less than 2 years, the rest period is extremely extended, and the hair does not enter the growth period.
本試験品には休止期毛を成長期に移行させる効果が認められるため、脱毛症治療薬や予防薬として有効である。 This test product is effective as a therapeutic agent for alopecia and a prophylactic agent because it has the effect of shifting telogen hair to the growth phase.
すなわち、従来の育毛剤が間接的効果であるのに対して、本発明の育毛剤は直接的に育毛に効果があり、効率的な育毛を可能とする。
本発明におけるビフラボン類とは、一般式
That is, while the conventional hair restorer has an indirect effect, the hair restorer of the present invention is directly effective for hair growth and enables efficient hair growth.
Biflavones in the present invention are general formulas
主なビフラボン類としては、シアドピティシン(Sciadopitysin)、ギンクゲチン(Ginkgetin)、イソギンクゲチン(Isoginkgetin)、セコイアフラボン(Sequoiaflavone)、ビロベチン(Bilobetin)及びアメントフラボン(Amentoflavone)があるが、それらの化学式は以下の通りである。 The main biflavones are Siadopitysin, Ginkgetin, Isoginkgetin, Sequoiaflavone, Bilobetin, and Amentoflavone. It is.
ビフラボンは、主としてイチョウ葉に含まれているが、他にはビャクシン属植物、イチイ属植物、イワヒバ属植物、マキ属植物等にも含まれている。 Biflavones are mainly contained in ginkgo biloba leaves, but are also contained in juniper plants, yew plants, flax genus plants and persimmon plants.
本発明のビフラボン類を育毛剤として用いるには、常法に従い、たとえば乳液、クリーム、ローション、ジェル、エアゾール等通常毛髪用化粧料として知られる種々の形態の基材に配合して、ヘアトニック、ヘアリキッド、ヘアローション、ヘアクリーム等とすることができる。 In order to use the biflavones of the present invention as a hair-growth agent, according to conventional methods, for example, blended with various forms of base materials known as cosmetics for normal hair such as emulsions, creams, lotions, gels, aerosols, hair tonics, It can be a hair liquid, a hair lotion, a hair cream, or the like.
本発明の育毛剤にはワセリン、オリーブ油等の油分、メントール等の清涼剤、抗菌剤、保湿剤、色素、香料等の公知の添加剤を配合することができるのは言うまでもない。
適用量は、大人の場合1〜2%程度の製剤を約5cc程度毎日1塗布することが好ましい。
Needless to say, the hair restorer of the present invention can be blended with known additives such as oils such as petrolatum and olive oil, refreshing agents such as menthol, antibacterial agents, moisturizers, pigments and fragrances.
In the case of adults, it is preferable to apply about 1 to 2% of a preparation daily about 5 cc.
また、本発明において育毛剤とは、発毛・育毛促進効果及び抜け毛や、ふけ・かゆみを防止する効果を有するものである。 Further, in the present invention, the hair growth agent has an effect of promoting hair growth / hair growth and preventing hair loss and dandruff / itch.
本発明の育毛剤は直接的に育毛に効果があり、効率的な育毛を可能とする。 The hair restorer of the present invention is directly effective for hair growth and enables efficient hair growth.
[実施例1] イチョウ葉エキスからビフラボン類の精製
イチョウ葉エキス(イチョウ葉産業株式会社製)10.0gをメタノール600mlに混合した後、分液ロートに移し、その混液をヘキサンで洗浄した(初回400ml、2回目以降は200ml×3回)。
[Example 1] Purification of biflavones from ginkgo biloba extract After mixing 10.0 g of ginkgo biloba extract (manufactured by Ginkgo biloba industry) into 600 ml of methanol, the mixture was transferred to a separatory funnel and the mixture was washed with hexane (first time) 400ml, 200ml x 3 times for the second and subsequent times).
メタノール層から吸引ろ過により不溶物を取り除いた後、ろ液を濃縮し、残渣8.73gを得た。この残渣をクロロフォルム:メタノール=9:1の溶媒200mlと水100mlで分画した。 After removing insolubles from the methanol layer by suction filtration, the filtrate was concentrated to obtain 8.73 g of a residue. This residue was fractionated with 200 ml of a solvent of chloroform: methanol = 9: 1 and 100 ml of water.
水層はクロロフォルム:メタノール=9:1の溶媒で抽出し(50ml×4回)、得られた有機層を全て合わせた。硫酸ナトリウムを加えて脱水し、ろ過した後濃縮して抽出エキス0.39gを得た。 The aqueous layer was extracted with a solvent of chloroform: methanol = 9: 1 (50 ml × 4 times), and all the obtained organic layers were combined. Sodium sulfate was added to dehydrate, filtered, and concentrated to obtain 0.39 g of extract.
上記の方法により得られた抽出エキス0.39gをシリカゲルカラムクロマトグラフィー(酢酸エチル:ヘキサン=1:1)に供し、ギンコール酸などの脂質成分を除いたビフラボン混合物を0.28gを得た。これはシアドピティシン(Sciadopitysin)、ギンクゲチン(Ginkgetin)、イソギンクゲチン(Isoginkgetin)、ビロベチン(Bilobetin)及びアメントフラボン(Amentoflavone)の各ビフラボン類の混合物であることが、高速液体クロマトグラフィーの分析により明らかとなった(図1)。 0.39 g of the extract obtained by the above method was subjected to silica gel column chromatography (ethyl acetate: hexane = 1: 1) to obtain 0.28 g of a biflavone mixture from which lipid components such as ginkgolic acid were removed. High-performance liquid chromatographic analysis revealed that this is a mixture of biflavones of Sciadopitysin, Ginkgetin, Isoginkgetin, Isobeckin, Bilobetin, and Amentoflavone. (Figure 1).
このビフラボン混合物をシリカゲル薄層クロマトグラム(酢酸エチル:ヘキサン=1:1)により分画し、各種ビフラボン類を主成分とする5個のフラクション(Fr.1:55mg、Fr.2:102mg、Fr.3:34mg、Fr.4:20mg、Fr.5:35mg)を得た。 This biflavone mixture was fractionated by silica gel thin layer chromatogram (ethyl acetate: hexane = 1: 1), and 5 fractions (Fr. 1:55 mg, Fr. 2: 102 mg, Fr. 3:34 mg, Fr. 4:20 mg, Fr. 5:35 mg).
高速液体クロマトグラフィーの分析の結果、Fr.1にはシアドピティシン(Sciadopitysin)が含まれ、Fr.2にはギンクゲチン(Ginkgetin)とイソギンクゲチン(Isoginkgetin)が約1:2の割合で含まれ、Fr.3にはギンクゲチン(Ginkgetin)とイソギンクゲチン(Isoginkgetin)が約1:7の割合で含まれ、Fr.4にはビロベチン(Bilobetin)が主に含まれることがわかった。アメントフラボン(Amentoflavone)は少量しか含まれず、分離できなかったので、市販のものを購入した(Fluka Chemical Co.Milwaukee,WI,USA)。 As a result of analysis by high performance liquid chromatography, Fr. 1 includes Sciadopitysin, and Fr. 2 contains Ginkgetin and Isoginkgetin in a ratio of about 1: 2, Fr. 3 contains Ginkgetin and Isoginkgetin in a ratio of about 1: 7. 4 was found to contain mainly bilobetin. Amentoflavone contained only a small amount and could not be separated, so a commercially available product was purchased (Fluka Chemical Co. Milwaukee, WI, USA).
[実施例2] ビフラボン類のヒト表皮角化細胞(HEKs)に対する増殖促進活性
Fr.1からFr.4及びアメントフラボン(Amentoflavone)のヒト表皮角化細胞(HEKs)に対する増殖促進活性を調べた。ヒト表皮角化細胞(HEKs)は、予備培養後、各検体の存在下、120時間培養した。細胞数をWST1を用いた比色法により求め検定した。ヒト表皮角化細胞(HEKs)は、毛包上皮細胞類縁細胞であり、この細胞の増殖を促進する物質は、育毛活性を導き出せる。
[Example 2] Growth promoting activity of biflavones on human epidermal keratinocytes (HEKs)
Fr. 1 to Fr. 4 and Amentoflavone (Amentoflavone) were examined for their growth-promoting activity against human keratinocytes (HEKs). Human epidermal keratinocytes (HEKs) were cultured for 120 hours in the presence of each specimen after preculture. The number of cells was determined by a colorimetric method using WST1. Human epidermal keratinocytes (HEKs) are hair follicle epithelial cell-related cells, and substances that promote the proliferation of these cells can induce hair-growth activity.
検体の濃度はFr.1が、シアドピティシン(分子量:580)、Fr.2が、ギンクゲチン(分子量:566):イソギンクゲチン(分子量:566)=1:2、Fr.3がギンクゲチン:イソギンクゲチン=1:7、Fr.4がビロベチン(分子量:553)として計算した。結果を図2に示す。 The sample concentration is Fr. 1 is cyanadopiticin (molecular weight: 580), Fr. 2 is ginkgotin (molecular weight: 566): isoginkgetin (molecular weight: 566) = 1: 2, Fr. 3 is Ginkgogetin: Isochinkugetin = 1: 7, Fr. 4 was calculated as virobetin (molecular weight: 553). The results are shown in FIG.
シアドピティシンを主成分とするFr.1は0.1μMから50μMの範囲で用量依存的に細胞増殖を増加させた。50μMにおいて最も高い活性170%を示した。ギンクゲチン、イソギンクゲチンを主成分とするFr.2とFr.3も0.1μMから50μMの範囲で細胞増殖活性を示した。Fr.2は0.1μMで最も高い活性138%を示した。0.1μMから50μMの範囲ではFr.1よりも低い活性であった。ビロベチンを主成分とするFr.4もFr.2、3と同様か、やや下回る活性を示した。一方、アメントフラボンはいずれの濃度でも細胞増殖効果を示さなかった。高濃度(100μM)においては、Fr.1〜4のいずれも細胞毒性を示した。 Fr. 1 increased cell proliferation in a dose-dependent manner in the range of 0.1 μM to 50 μM. The highest activity was 170% at 50 μM. Fr. 2 and Fr. 3 also showed cell proliferation activity in the range of 0.1 μM to 50 μM. Fr. 2 showed the highest activity 138% at 0.1 μM. In the range of 0.1 μM to 50 μM, Fr. The activity was lower than 1. Fr. 4 is also Fr. The activity was the same as or slightly lower than 2 and 3. On the other hand, amentoflavone did not show cell proliferation effect at any concentration. At high concentrations (100 μM), Fr. Any of 1-4 showed cytotoxicity.
以上の結果からビフラボン中のメトキシル基の数が多いものほど増殖促進活性が高くなることが示唆された。すなわち、育毛作用に最も好ましいビフラボンは、シアドピティシンであり、次いでギンクゲチン及びイソギンクゲチンの混合物であることが分かった。
なお、図2の増殖促進活性率を表1に数値で示す。
From the above results, it was suggested that as the number of methoxyl groups in biflavone increases, the growth promoting activity increases. That is, it was found that the most preferred biflavone for hair growth action is cyanadopiticin, followed by a mixture of ginkgetin and isoginkgetin.
The growth promoting activity rate in FIG.
表1は、対照の細胞増殖率を100%としたときの、検体の細胞増殖率を示す。表皮角化細胞(HEK)は、各濃度の検体を含む培地中で120時間培養した。対照には検体を含まない培地を用いた。細胞増殖率は平均値±S.E.M(n=6)で示した。 Table 1 shows the cell growth rate of the specimen when the cell growth rate of the control is 100%. Epidermal keratinocytes (HEK) were cultured for 120 hours in a medium containing each concentration of specimen. As a control, a medium containing no specimen was used. The cell growth rate is shown as an average value ± S.E.M (n = 6).
[実施例3] マウス発毛試験
1%ビフラボン混合物(シアドピティシン、ギンクゲチン、イソギンクゲチン、ビロベチン、アメントフラボン)を試験品とし、対照として1%エタノール、また標準品(ポジティブな対照)として1%ミノキシジルを用いた。なお、ミノキシジルは医薬品として、厚生労働省から許可された有効性の高い発毛剤である。本試験品である1%ビフラボン混合物はエタノールに溶解させた。
[Example 3] Mouse
C3Hのマウスの背部毛は、時間的同調サイクルがあることが知られており、18−21日令と47−95日令から背部毛は休止期に入る。そこで、これら試験品、対照品、標準品を、ヘアーサイクルが休止期にある7週令のC3H/HeSlc雄マウス(ジャパンSLC、静岡・日本)の背部の毛を剃った個所にそれぞれ200μLを1日1回塗布した。試験開始後40日目にマウスの背部の皮膚を観察した結果が図3に示されている。 The back hair of C3H mice is known to have a time-synchronized cycle, and the back hair enters a resting state from 18-21 days and 47-95 days. Therefore, 200 μL each of these test products, control products, and standard products was shaved on the back of 7-week-old C3H / HeSlc male mice (Japan SLC, Shizuoka, Japan) whose hair cycle was at rest. It was applied once a day. The result of observing the skin on the back of the mouse on the 40th day after the start of the test is shown in FIG.
図3−aは対照品による発毛状況の写真であり、図3−bは本試験品による発毛状況の写真であり、図3−cは標準品による発毛状況の写真である。 FIG. 3-a is a photograph of the hair growth situation with the control product, FIG. 3-b is a photograph of the hair growth situation with the test product, and FIG. 3-c is a photograph of the hair growth situation with the standard product.
ポジティブな標準品であるミノキシジルの塗布では背部皮膚の99%が毛で覆われていた。一方、エタノールを塗布した対照品ではわずか23%のみ毛で覆われているにすぎなかった。しかし、本試験品が塗布された群では、標準品とほぼ同等の95%が毛で覆われていた。 The application of minoxidil, a positive standard, covered 99% of the back skin with hair. On the other hand, only 23% of the control product coated with ethanol was covered with hair. However, in the group to which this test product was applied, 95%, which was almost equivalent to the standard product, was covered with hair.
これらの結果はビフラボン混合物が毛の成長を誘発する著しい発毛活性を有していることを示している。 These results indicate that the biflavone mixture has significant hair growth activity that induces hair growth.
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005194887A JP2007008900A (en) | 2005-07-04 | 2005-07-04 | Hair growth promoter containing biflavones as active component |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005194887A JP2007008900A (en) | 2005-07-04 | 2005-07-04 | Hair growth promoter containing biflavones as active component |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2007008900A true JP2007008900A (en) | 2007-01-18 |
Family
ID=37747849
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005194887A Pending JP2007008900A (en) | 2005-07-04 | 2005-07-04 | Hair growth promoter containing biflavones as active component |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2007008900A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007086327A1 (en) * | 2006-01-24 | 2007-08-02 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Dermal papilla cell growth promoter |
| JP2008074748A (en) * | 2006-09-20 | 2008-04-03 | Nihon Kolmar Co Ltd | Skin preparation |
| CN109867651A (en) * | 2019-04-09 | 2019-06-11 | 山东中医药大学附属医院 | A method of extracting Sciadopitysin from ginkgo leaf |
| JP2022510097A (en) * | 2018-11-29 | 2022-01-26 | アモーレパシフィック コーポレーション | Composition for hair loss or skin inflammation suppression |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002199858A (en) * | 2001-01-08 | 2002-07-16 | Fusao Takimoto | Healthy food containing dried bean curd powder as main component |
| WO2005046584A2 (en) * | 2003-11-05 | 2005-05-26 | Osteoscreen, Inc. | Stimulation of hair growth by ginkgo biloba flavanoids |
-
2005
- 2005-07-04 JP JP2005194887A patent/JP2007008900A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002199858A (en) * | 2001-01-08 | 2002-07-16 | Fusao Takimoto | Healthy food containing dried bean curd powder as main component |
| WO2005046584A2 (en) * | 2003-11-05 | 2005-05-26 | Osteoscreen, Inc. | Stimulation of hair growth by ginkgo biloba flavanoids |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007086327A1 (en) * | 2006-01-24 | 2007-08-02 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Dermal papilla cell growth promoter |
| JP2008074748A (en) * | 2006-09-20 | 2008-04-03 | Nihon Kolmar Co Ltd | Skin preparation |
| JP2022510097A (en) * | 2018-11-29 | 2022-01-26 | アモーレパシフィック コーポレーション | Composition for hair loss or skin inflammation suppression |
| JP7441217B2 (en) | 2018-11-29 | 2024-02-29 | アモーレパシフィック コーポレーション | Composition for hair removal or skin inflammation suppression |
| CN109867651A (en) * | 2019-04-09 | 2019-06-11 | 山东中医药大学附属医院 | A method of extracting Sciadopitysin from ginkgo leaf |
| CN109867651B (en) * | 2019-04-09 | 2021-01-05 | 山东中医药大学 | Method for extracting sciadopitysin from ginkgo leaves |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7758679B2 (en) | Method for obtaining an aqueous extract of lavender, compositions containing such extracts, and cosmetic uses thereof | |
| EP3335693B1 (en) | Composition for external use | |
| JP2010533143A (en) | AGE deglycosylation | |
| EP3478309B1 (en) | Novel silybum marianum achene extract and uses thereof in dermatology and dermo-cosmetics | |
| JP6077560B2 (en) | Skin external preparation composition containing white-bellied extract | |
| JP2004189683A (en) | Ceramide production promoter | |
| JP2008303147A (en) | External preparation for skin | |
| JP2004210743A (en) | Agent for promoting production of ceramide | |
| JP2002179592A (en) | Composition for removing abnormal proteins | |
| JP5888563B2 (en) | Moisturizer, rough skin improving agent, stratum corneum moisture increasing agent, blood flow improving agent and skin dullness, bear or gloss improving agent | |
| JP2007008900A (en) | Hair growth promoter containing biflavones as active component | |
| WO2012108494A1 (en) | Deodorant containing polyvalent alcohol | |
| TWI887200B (en) | External composition containing ascorbic acid and/or its salt, and method for preventing coloration and/or crystal precipitation of external composition | |
| KR101877803B1 (en) | Skin external composition containing floral ginsenoside | |
| JP7456720B2 (en) | Ceramide production promoter | |
| JP2000239145A (en) | Anti-allergic agent, beautifully whitening agent and skin cosmetic | |
| CN106265113A (en) | The compositions comprising obacunone and the method using said composition in skin anti-aging is applied | |
| JP4083111B2 (en) | β-endorphin production promoter | |
| JP2016502976A (en) | Cosmetic use of a combination of carob embryo extract and caffeine as an agent for weight loss | |
| JP2002284648A (en) | Hair restorer composition | |
| KR102027349B1 (en) | Composition of skin external application containing polysaccharides, and the method for preparing thereof | |
| JP7246125B2 (en) | Epidermal cell activator | |
| KR102843044B1 (en) | Composition containing exosome derived from Solanum lycopersicum fruit extract | |
| JP2001261567A (en) | Skin care preparation | |
| KR20150034371A (en) | Cosmetic composition comprising the extract of Commelina communis as anti-wrinkle ingredient |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080612 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20100826 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110426 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20111101 |